FountainVest, Primavera invest $557m in China pharmacy chain
FountainVest Partners and Primavera Capital have paid $557 million for a 24.78% stake in Chinese pharmacy chain Laobaixing. It will provide a full exit for EQT Partners.
The two investors will each take approximately 12.4% shares via FountainVest China Capital Partners Fund III and Primavera Capital Fund III, according to a statement. EQT Partners became the second-largest...
More on Greater China
Latest News
China’s largest co-working player Ucommune files for US IPO
Ucommune, China’s largest co-working space player which is considered the local equivalent to troubled US operator WeWork, has filed for a US IPO.
Chinese drone maker EHang raises $40m in US IPO
Chinese drone manufacturer EHang traded flat on its NASDAQ debut following a $40 million IPO that priced at the bottom end of the indicative range.
Tiger Global leads round for Indian invoice discounting platform
Tiger Global Management has led a $26 million Series B round for Indian B2B financing platform provider KredX.
New Zealand impact fund backs sustainable packaging player
New Zealand’s Impact Enterprise Fund (IEF) has confirmed an investment in local sustainable packaging supplier Grounded.